Cue Biopharma, INC. (CUE) SEC Filings — 2024
17 SEC filings for Cue Biopharma, INC. (CUE) in 2024.
Filings
- Cue Biopharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Cue Biopharma Files 8-K on Shareholder Votes and Financials — 8-K · Oct 8, 2024
- Cue Biopharma Enters Material Definitive Agreement — 8-K · Oct 4, 2024
- Cue Biopharma Enters Material Definitive Agreement — 8-K · Sep 27, 2024
- Cue Biopharma Files Definitive Proxy Statement — DEF 14A · Sep 10, 2024
- Cue Biopharma Files 8-K on Executive and Director Changes — 8-K · Sep 3, 2024
- Cue Biopharma Faces Nasdaq Delisting — 8-K · Aug 16, 2024
- Cue Biopharma Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- Cue Biopharma Appoints New CMO, Adds Director — 8-K · Jul 25, 2024
- Cue Biopharma Files 8-K on Director/Officer Changes — 8-K · Jun 7, 2024
- Cue Biopharma Files Proxy Materials — DEFA14A · May 24, 2024
- Cue Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Cue Biopharma, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 26, 2024
- Cue Biopharma Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Cue Biopharma, INC. SC 13G Filing — SC 13G · Mar 11, 2024
- BlackRock Discloses 5.1% Stake in Cue Biopharma — SC 13G · Feb 7, 2024
- BlackRock Discloses Passive Stake in Cue Biopharma — SC 13G · Jan 31, 2024